Bridging Tumor Genomics to Patient Outcomes through an Integrated Patient-Derived Xenograft (PDX) Platform

New approaches to optimizing cancer drug development in both the laboratory and the clinic will be required to fully achieve the goal of individualized, precision cancer therapy. Improved preclinical models that more closely reflect the now recognized genomic complexity of human cancers are needed....

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Clin Lung Cancer
Glavni autori: Gandara, David R., Mack, Philip. C., Bult, Carol, Li, Tianhong, Lara, Primo N., Riess, Jonathan W., Astrow, Stephanie H., Gandour-Edwards, Regina, Cooke, David T., Yoneda, Ken Y., Moore, Elizabeth H., Pan, Chong-xian, Burich, Rebekah A., David, Elizabeth A., Keck, James G., Airhart, Susan, de Vere White, Ralph W., Liu, Edison T.
Format: Artigo
Jezik:Inglês
Izdano: 2015
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4586173/
https://ncbi.nlm.nih.gov/pubmed/25838158
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cllc.2015.03.001
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items